Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Review ArticleReview

Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?

Yu-Ling Li, Hua Zhao and Xiu-Bao Ren
Cancer Biology & Medicine June 2016, 13 (2) 206-214; DOI: https://doi.org/10.20892/j.issn.2095-3941.2015.0070
Yu-Ling Li
1Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Zhao
1Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
2Key Laboratory of Cancer Immunology and Biotherapy, Research Center of Lung Cancer, Tianjin 300060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiu-Bao Ren
1Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
2Key Laboratory of Cancer Immunology and Biotherapy, Research Center of Lung Cancer, Tianjin 300060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1

    The influence of VEGF on different immune and cancer cells

    Cell typeThe influence of VEGF on the cellReference
    Dendritic cellInhibit the differentiation of DC in the hematopoietic process30
    Influence the function and maturation of DC29
    Increase the mDC and pDC in lung32
    Enable DC to differentiate into endothelial-like cell33
    Enable DC to get an angiogenic property34
    MacrophagePrevent inflammation during bacterial infection35
    Mediate the infiltration of macrophage in the lung36
    T lymphocyteCause thymic atrophy37
    Costimulate IFN-γ production, increase chemotaxis38
    Induce epithelial activation, neutrophil chemotaxis in OAD39
    TregPromote the induction and maintenance of Treg in the tumor site40
    Chemotaxis for Treg5
    Tumor cellIncrease the migration, cell mobility and invasiveness of tumor cells41–43
    Promote cancer stemness44

    VEGF, vascular endothelial growth factor; DC, dendritic cell; mDC, myeloid DC; pDC, plasmacytoid DC; OAD, obliterative airway disease.

      • View popup
      Table 2

      Expression of VEGF receptors in different immune and cancer cells

      Cell typeExpression of VEGF receptorsReference
      Hematopoietic cellVEGFR-130
      Dendritic cellVEGFR-328
      MacrophageVEGFR-1, VEGFR-353–55
      T lymphocyteVEGFR-1, VEGFR-238,56
      Treg tumor cellVEGFR-2, NRP-140
      VEGFR-1, VEGFR-2, NRP-157,58
    PreviousNext
    Back to top

    In this issue

    Cancer Biology and Medicine: 13 (2)
    Cancer Biology & Medicine
    Vol. 13, Issue 2
    1 Jun 2016
    • Table of Contents
    • Index by author
    Print
    Download PDF
    Email Article

    Thank you for your interest in spreading the word on Cancer Biology & Medicine.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?
    (Your Name) has sent you a message from Cancer Biology & Medicine
    (Your Name) thought you would like to see the Cancer Biology & Medicine web site.
    Citation Tools
    Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?
    Yu-Ling Li, Hua Zhao, Xiu-Bao Ren
    Cancer Biology & Medicine Jun 2016, 13 (2) 206-214; DOI: 10.20892/j.issn.2095-3941.2015.0070

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?
    Yu-Ling Li, Hua Zhao, Xiu-Bao Ren
    Cancer Biology & Medicine Jun 2016, 13 (2) 206-214; DOI: 10.20892/j.issn.2095-3941.2015.0070
    Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Introduction
      • Biology of VEGF
      • Biology of VEGFRs
      • Relationship between VEGF/VEGFR and DCs
      • Relationship between VEGF/VEGFR and macrophages
      • Relationship between VEGF/VEGFR and T cells
      • VEGF can be secreted by tumor cells and further stimulate cancer stemness
      • Conclusions
      • Acknowledgements
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • References
    • PDF

    Related Articles

    • No related articles found.
    • Google Scholar

    Cited By...

    • Conventional therapy induces tumor immunoediting and modulates the immune contexture in colorectal cancer
    • Epigenetic Reprogramming Mediates Monocyte and Heterologous T Cell-derived Cytokine Responses after BCG Vaccination
    • Dual role of Vascular Endothelial Growth Factor-C (VEGF-C) in post-stroke recovery
    • Unlocking G-Quadruplexes as Antiviral Targets
    • Google Scholar

    More in this TOC Section

    • The mechanisms and clinical significance of CD8+ T cell exhaustion in anti-tumor immunity
    • Senescent macrophages in cancer: roles in tumor progression and treatment opportunities
    • Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer
    Show more Review

    Similar Articles

    Keywords

    • Vascular endothelial growth factor (VEGF)
    • VEGF receptors (VEGFRs)
    • dendritic cell (DC)
    • macrophage
    • T lymphocyte
    • tumor

    Navigate

    • Home
    • Current Issue

    More Information

    • About CBM
    • About CACA
    • About TMUCIH
    • Editorial Board
    • Subscription

    For Authors

    • Instructions for authors
    • Journal Policies
    • Submit a Manuscript

    Journal Services

    • Email Alerts
    • Facebook
    • RSS Feeds
    • Twitter

     

    © 2025 Cancer Biology & Medicine

    Powered by HighWire